Perceptive Xontogeny Venture Fund, LP's Net Worth

Trade with PublicCompare Brokers
$0

Estimate Recalculated Nov 1, 2024 10:19AM EST

Who is Perceptive Xontogeny Venture Fund, LP

Perceptive Xontogeny Venture Fund, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LianBio, Landos Biopharma, Inc., Astria Therapeutics, Inc., and Solid Biosciences Inc..

SEC CIK

Perceptive Xontogeny Venture Fund, LP's CIK is 0001757940

Past Insider Trading and Trends

No data available

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LianBio

Investor
Updated Aug 22, 2022
Form 4
36.56%
998.24K
$2.40
$2.40M
Aug 22, 2022
57.56M
Purchase
—Aug 18
Form 4
2.59%
69.00K
$3.13
$215.97K
May 27, 2022
56.56M
Purchase
—May 26
Form 4
6.88%
171.25K
$2.58
$442.36K
May 25, 2022
56.49M
Purchase
—May 23 - May 25
Form 4
8.87%
2.27M
$15.98
$36.27M
Nov 05, 2021
56.32M
Purchase
—Nov 03
Form 4
145.30%
32.02M
$14.59
—
Nov 03, 2021
54.05M
Purchase
—Nov 01 - Nov 03
Form 3
————
Oct 29, 2021
15.47M
—
——
Showing 6 results

Landos Biopharma, Inc.

Investor
Updated Jan 11, 2023
Form 4
—
30.91M
$0.54
$16.69M
Jan 11, 2023
30.91M
Purchase
—Jan 10
Form 4
—
25.29K
——
Aug 31, 2021
25.29K
Grant
—Aug 27
Form 4
3.55%
250.19K
$12.84
$3.21M
Feb 09, 2021
17.96M
Purchase
—Feb 05 - Feb 09
Form 4
5.65%
1.25M
$16.00
$20.00M
Feb 08, 2021
26.45M
Purchase
—Feb 08
Form 3
————
Feb 03, 2021
3.09M
—
——
Showing 5 results

Astria Therapeutics, Inc.

Investor
Updated Feb 05, 2024
Form 4
103.72%
2.48M
$12.09
$30.00M
Feb 05, 2024
6.49M
Purchase
—Feb 01
Form 4
44.78%
740.00K
$6.20
$4.59M
Dec 22, 2023
4.00M
Purchase
—Dec 21
Form 4
185.55%
3.99M
$6.51
$26.00M
Oct 18, 2023
6.14M
Purchase
—Oct 16
Form 4
698.43%
908.26K
$11.01
$10.00M
Dec 21, 2022
2.19M
Purchase
—Dec 19
Form 4
22.07%
6.47K
$3,009.53
$19.47M
Feb 03, 2021
35.77K
Grant
—Feb 01
Form 3
————
Feb 03, 2021
2.48M
—
——
Showing 6 results

Solid Biosciences Inc.

Investor
Updated Jan 12, 2024
Form 4
99.65%
3.41M
$5.53
$18.86M
Jan 12, 2024
6.91M
Purchase
—Jan 11
Form 4
290.97%
2.60M
$7.05
—
Dec 06, 2022
3.50M
Grant
—Dec 02
Showing 2 results
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved